Zoliget 30 mg + 4 mg

Indication

Management of type 2 diabetes mellitus in adults as an adjunct to diet and exercise when adequate glycaemic control is not achieved with pioglitazone or glimepiride monotherapy.

Ingredients

• Pioglitazone (as HCl) 30 mg
• Glimepiride USP 4 mg

Direction

As directed by the physician. See package insert for full prescribing information. Do not store above 30°C. Protect from sunlight and moisture.

Side effects

• Consult a doctor or pharmacist if any adverse effects occur. Stop use and seek immediate medical attention if signs of serious allergic reaction appear.

Precautions

• Consult a doctor or pharmacist before use. Stop use and seek medical attention if allergic reaction or signs of liver problems occur. Not for use in type 1 diabetes or diabetic ketoacidosis.